Zilretta® (triamcinolone acetonide extended-release injectable suspension)

Covered only as a single 32 mg intra‑articular injection for osteoarthritis pain of the knee (use in other joints and re‑treatment with Zilretta are excluded). Coverage requires radiologic confirmation of knee OA, documentation of a prior intra‑articular corticosteroid injection with an inadequate response, confirmation the knee has not previously received Zilretta, and supporting clinical notes.

"Zilretta is indicated as an intra-articular injection for the management of osteoarthritis pain of the knee."

Sign up to see full coverage criteria, indications, and limitations.